Aspen enters JV for possible manufacture of Covid-19 vaccine candidate in PE
Aspen subsidiary Pharmacare, which trades as Aspen Pharmacare, has entered into a preliminary agreement with Janssen Pharmaceuticals and Janssen Pharmaceutica for the technical transfer and proposed commercial manufacture of their Covid-19 vaccine candidate, Ad26.COV2-S.
The agreement is still subject to the successful completion of the relevant technology transfer activities and finalisation of certain commercial manufacturing terms, but Aspen Pharmacare has agreed to provide the necessary capacity required for the manufacture of Johnson & Johnson’s Covid-19 vaccine candidate at its existing sterile facility in Port Elizabeth.
Janssen Pharmaceuticals and Janssen Pharmaceutica are two of the Janssen Pharmaceutical Companies of Johnson & Johnson.
The vaccine candidate is currently undergoing clinical trials.
Aspen Pharmacare will perform formulation, filling and secondary packaging of the vaccine for supply to Johnson & Johnson.
Aspen has invested in excess of R3-billion in the facility containing the high-technology equipment and systems that will be used to manufacture state-of-the-art sterile drugs and vaccines, packaged into vials, ampoules and pre-filled syringes.
The production area where it is intended that the vaccine candidate will be manufactured has capacity to produce more than 300-million doses a year, and the facility has accreditation from a range of international regulatory authorities and provides lifesaving medicines to both the domestic and international markets.
The facility was part of the first flagship investments announced at President Cyril Ramapahosa’s inaugural South Africa Investment Conference in 2018.
Comments
The
content
you are trying to access is only available to subscribers.
If you are already a subscriber, you can Login Here.
If you are not a subscriber, you can subscribe now, by selecting one of the below options.
For more information or assistance, please contact us at subscriptions@creamermedia.co.za.
Option 1 (equivalent of R125 a month):
Receive a weekly copy of Creamer Media's Engineering News & Mining Weekly magazine
(print copy for those in South Africa and e-magazine for those outside of South Africa)
Receive daily email newsletters
Access to full search results
Access archive of magazine back copies
Access to Projects in Progress
Access to ONE Research Report of your choice in PDF format
Option 2 (equivalent of R375 a month):
All benefits from Option 1
PLUS
Access to Creamer Media's Research Channel Africa for ALL Research Reports, in PDF format, on various industrial and mining sectors
including Electricity; Water; Energy Transition; Hydrogen; Roads, Rail and Ports; Coal; Gold; Platinum; Battery Metals; etc.
Already a subscriber?
Forgotten your password?
Receive weekly copy of Creamer Media's Engineering News & Mining Weekly magazine (print copy for those in South Africa and e-magazine for those outside of South Africa)
➕
Recieve daily email newsletters
➕
Access to full search results
➕
Access archive of magazine back copies
➕
Access to Projects in Progress
➕
Access to ONE Research Report of your choice in PDF format
RESEARCH CHANNEL AFRICA
R4500 (equivalent of R375 a month)
SUBSCRIBEAll benefits from Option 1
➕
Access to Creamer Media's Research Channel Africa for ALL Research Reports on various industrial and mining sectors, in PDF format, including on:
Electricity
➕
Water
➕
Energy Transition
➕
Hydrogen
➕
Roads, Rail and Ports
➕
Coal
➕
Gold
➕
Platinum
➕
Battery Metals
➕
etc.
Receive all benefits from Option 1 or Option 2 delivered to numerous people at your company
➕
Multiple User names and Passwords for simultaneous log-ins
➕
Intranet integration access to all in your organisation